News – Page 1035 – Endpoints News

Top Celgene exec pins the blame for ozanimod fiasco on the Receptos team — acquired 3 years ago

7 years ago

Little vTv Therapeutics adds another round of bad data on Alzheimer's drug, but they still love their chances

7 years ago

Cellectis, rising star Allogene design an 'all-in-one' CAR construct with embedded safety switch as the new partners ...

7 years ago

Stepping into the pricing debate, FDA chief Scott Gottlieb proposes new reimbursement idea for antibiotics

7 years ago

Idera shares slide on PhII failure; WuXi blueprints $60M manufacturing center in Worcester, MA

7 years ago

Prominent cancer biologist Inder Verma resigns from Salk in wake of sexual harassment allegations

7 years ago

Galmed's stock rockets up as execs tout a mixed set of NASH data

7 years ago

GSK’s high-level management makeover continues as CEO Emma Walmsley oversees changing of the guard

7 years ago

Roche CEO Severin Schwan isn’t about to tamper with a winning R&D strategy now, but he’s still looking for ways ...

7 years ago

With a big assist from the FDA, Sage plots a swift march through PhIII for oral depression drug -- market cap swells ...

7 years ago

Novartis hands Regenxbio $100M in fast cash for vector tech

7 years ago

PhIII Alzheimer’s drug goes bust — and a major setback at Eli Lilly and AstraZeneca may doom the class

7 years ago

Gene editing stocks get bushwhacked as new studies highlight CRISPR/Cas9 cancer risks

7 years ago

BridgeBio bags Alexion's ultra-rare disease asset; Allergan touts a new set of late-stage data for oral CGRP drug

7 years ago

Act One: Anti-aging team at Juvenescence adds $50M to the cache as it builds steam on development efforts

7 years ago

AI team at Insilico gets some major league backing from China as Alex Zhavoronkov builds global network

7 years ago

After cash funneling scandal, biotech billionaire Soon-Shiong charges on with Nant IPO

7 years ago

Bitterly opposed old guard at Takeda wages a last-ditch fight to block 'foreign blood's' $62B Shire buyout

7 years ago

Alexion cautiously steps over to the C6 pathway with an early-stage development deal tied to buyout option

7 years ago

Sanofi builds on mRNA alliances with an $805M pact for Ron Renaud’s Translate Bio

7 years ago

AbbVie, Roche post a big win with a blockbuster FDA OK for Venclexta/Rituxan combo for leukemia

7 years ago

Strike two: Vical says another one of its vaccines has crashed and burned in PhII

7 years ago

Visualize: ASCO 2018's winners and losers

8 years ago

Rubius snaps up Novartis vet Pablo Cagnoni as CEO; MiMedx dumps two execs following internal investigation

8 years ago

First page Previous page 1032 1033 103410351036 1037 1038 Next page Last page